Skip to content

About Us
Technology
Pipeline
- Overview
- Migaldendranib (MGB)
News
Resources
Careers
Contact

About Us
Technology
Pipeline
- Overview
- Migaldendranib (MGB)
News
Resources
Careers
Contact

Resources

All Resources

May 22, 2023 | Publications

Clinical Radiosynthesis and Translation of [ 18F]OP-801: A Novel Radiotracer for Imaging Reactive Microglia and Macrophages

April 1, 2023 | Publications

Targeted Nanomedicine: Ashvattha Therapeutics’ Path to Developing Hydroxyl Dendrimers

July 20, 2022 | Publications

Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial

Science Translational Medicine

July 1, 2021 | Publications

Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration

Journal of Controlled Release

April 8, 2020 | Publications

Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration

AIChE

September 1, 2016 | Publications

Nanoscale effects in dendrimer-mediated targeting of neuroinflammation

Science Direct

April 18, 2012 | Publications

Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit Model

Science Translational Medicine

August 1, 2008 | Publications

The effect of surface functionality on cellular trafficking of dendrimers

Science Direct

© Copyright 2025 Ashvattha Therapeutics.

Privacy Policy

© 2025 Ashvattha Therapeutics • Built with GeneratePress